Alafair Biosciences raises over $7.2 million in series B/B-1 financing
Alafair Biosciences announced that it raised over $7.2 million in an oversubscribed Series B/B-1 financing to fund its next phase of growth. The proceeds will be used to accelerate the commercialization of VersaWrap® Tendon Protector. April 24, 2019